Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Breast Neoplasms 4 Ovarian Neoplasms 3 Triple Negative Breast Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Overweight 2 Obesity 2 Multiple Myeloma 2 Motor Activity 2 Melanoma 2 Lung Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Weight Loss 1 Uveal Melanoma 1 Smoking Cessation 1 Quality of Life 1 Postoperative Complications 1 Patient Compliance 1 Neoplasms 1 Metabolic Syndrome 1 Localized Prostate Carcinoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Insulin Resistance 1 Inflammation 1 Hypothalamic Neoplasms 1 Healthy Diet 1 Glioma 1 Gastrointestinal Neoplasms 1

Interventions

Temozolomide 42 Magnetic Resonance Spectroscopy 41 Radiotherapy 22 Specimen Handling 18 Biopsy 13 X-Rays 10 Radiation 10 trametinib 8 Bevacizumab 8 Nivolumab 7 Blood Specimen Collection 7 olaparib 6 fluorodopa F 18 6 dabrafenib 6 Radiotherapy, Intensity-Modulated 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Lomustine 6 pembrolizumab 5 abemaciclib 5 Standard of Care 5 vorasidenib 4 ulixertinib 4 larotrectinib 4 ivosidenib 4 erdafitinib 4 Surgical Procedures, Operative 4 Dianhydrogalactitol 4 Cyclophosphamide 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Diet Therapy × 1 year × Clear all

NCT02286167 2026-03-24

GLAD

Wake Forest University Health Sciences

Phase NA Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡